BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
2.820
-0.130 (-4.41%)
Oct 16, 2026, 4:00 PM EDT - Market closed
BridgeBio Oncology Therapeutics Employees
BridgeBio Oncology Therapeutics had 88 employees as of June 30, 2026. The number of employees increased by 26 or 41.94% compared to the same quarter last year. That makes BridgeBio Oncology Therapeutics the 32,177th largest employer in the world and 4,160th in the United States.
Employees
88
Change
26
Growth
41.94%
Revenue / Employee
n/a
Profits / Employee
-$2,069,477
Market Cap
226.09M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 88 | 26 | 41.94% |
| Mar 31, 2026 | 106 | 44 | 70.97% |
| Dec 31, 2025 | 92 | 30 | 48.39% |
| Sep 30, 2025 | 81 | 19 | 30.65% |
| Mar 31, 2025 | 62 | - | - |
| Dec 31, 2024 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Fate Therapeutics | 161 |
| Cabaletta Bio | 158 |
| AC Immune | 122 |
| SAB Biotherapeutics | 86 |
| Lexeo Therapeutics | 63 |
| Immuneering | 57 |
| Vicore Pharma Holding AB | 46 |
BBOT News
- 5 days ago - BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - BridgeBio Oncology Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 5 weeks ago - JPMorgan cuts BridgeBio target, sees buying opportunity on selloff - TheFly
- 5 weeks ago - BridgeBio Oncology price target lowered to $27 from $39 at Leerink - TheFly
- 5 weeks ago - BridgeBio Oncology price target lowered to $22 from $24 at Raymond James - TheFly
- 5 weeks ago - BridgeBio Oncology price target lowered to $15 from $23 at Stifel - TheFly
- 5 weeks ago - BridgeBio Oncology price target lowered to $20 from $23 at Canaccord - TheFly
- 5 weeks ago - BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers - GlobeNewsWire